Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
AstraZeneca
Moodys
Harvard Business School
Merck

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Fluoxymesterone - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Prices for fluoxymesterone

See drug prices for fluoxymesterone

Recent Clinical Trials for fluoxymesterone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4
ASCEND TherapeuticsPhase 2

See all fluoxymesterone clinical trials

Pharmacology for fluoxymesterone
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for fluoxymesterone
Synonyms for fluoxymesterone
(11beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one
(1R,2S,10S,11S,14S,15S,17S)-1-fluoro-14,17-dihydroxy-2,14,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one
(8S,9R,10S,11S,13S,14S,17S)-9-fluoranyl-10,13,17-trimethyl-11,17-bis(oxidanyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
010F480
11-beta,17-beta-Dihydroxy-9-alpha-fluoro-17-alpha-methyl-4-androster-3-one
11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androsten-3-one
11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one
17-alpha-Methyl-9-alpha-fluoro-11-beta-hydroxytesterone
17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone
4-08-00-02057 (Beilstein Handbook Reference)
76-43-7
9-alpha-Fluoro-11-beta-hydroxy-17-methyltestosterone
9-alpha-Fluoro-11-beta,17-beta-dihydroxy-17-alpha-methyl-4-androstene-3-one
9-alpha-Fluoro-17-alpha-methyl-11-beta,17-dihydroxy-4-androsten-3-one
9-Fluoro-11-beta,17-beta-dihydroxy-17-methylandrost-4-en-3-one
9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one
9-fluoro-11beta,17beta-dihydroxy-17alpha-methylandrost-4-en-3-one
9.alpha.-Fluoro-11.beta.-hydroxy-17-methyltestosterone
9.alpha.-Fluoro-11.beta.,17.beta.-dihydroxy-17.alpha.-methyl-4-androstene-3-one
92481-EP2295416A2
92481-EP2295426A1
92481-EP2295427A1
92481-EP2298748A2
92481-EP2305642A2
9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone
9alpha-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one
9alpha-Fluoro-11beta,17beta-dihydroxy-17alpha-methyl-4-androstene-3-one
9alpha-Fluoro-17alpha-methyl-11beta,17-dihydroxy-4-androsten-3-one
9JU12S4YFY
A838701
AC-29744
AC1L1MJU
AI3-52940
AKOS015895109
AN-23896
Anadroid-F
Androfluorene
Androfluorone
Android-f
Androst-4-en-3-one, 9-fluoro-11-beta,17-beta-dihydroxy-17-methyl-
Androst-4-en-3-one, 9-fluoro-11,17-dihydroxy-17-methyl-, (11beta,17beta)-
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl-
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl- (VAN)
Androst-4-en-3-one, 9-fluoro-11beta,17beta-dihydroxy-17-methyl- (VAN) (8CI)
Androsterolo
Androxy
Androxy (TN)
BCP10776
BDBM18189
BRN 2008796
C-20222
CAS-76-43-7
CC-28509
CCRIS 9036
CHEBI:5120
CHEMBL1445
component of Halodrin
D00327
DB01185
DSSTox_CID_13512
DSSTox_GSID_33512
DSSTox_RID_79080
DTXSID8033512
EINECS 200-961-8
Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3
Fluoro-9-alpha dihydroxy-11-beta,17-beta methyl-17-alpha androstene-4 one-3 [French]
Fluossimesterone
Fluossimesterone [DCIT]
Fluosterone
Fluotestin
Fluoximesteron
Fluoximesterona
Fluoximesterona [INN-Spanish]
Fluoximesterone
Fluoximesteronum
Fluoxymesteron
Fluoxymesterone (JP17/USP/INN)
Fluoxymesterone [INN:BAN:JAN]
Fluoxymesterone [USP:INN:BAN:JAN]
Fluoxymesterone 1.0 mg/ml in Acetonitrile
Fluoxymesterone, 97.0-102.0%
Fluoxymesterone, solid (photosensitive)
Fluoxymesteronum
Fluoxymesteronum [INN-Latin]
Fluoxymestrone
Flusteron
Flutestos
FXM
GTPL2861
Halotestin
Halotestin (TN)
HMS2272B06
HSDB 3333
LMST02020025
LS-19496
MLS001055414
NCGC00091037-01
NCGC00091037-02
NCGC00182970-01
NCGC00258408-01
Neo-Ormonal
NSC 10704
NSC-10704
NSC-12165
NSC10704
NSC12165
Ora Testryl
Ora-Testryl
Oralsterone
Oratestin
PubChem5785
SCHEMBL5096
SMR000686158
Testoral
Testosterone, 9-fluoro-11.beta.-hydroxy-17-methyl-
Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-
Tox21_113158
Tox21_200854
U 6040
Ultandren
Ultandrene
UNII-9JU12S4YFY
W-104363
ZINC3875484

US Patents and Regulatory Information for fluoxymesterone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl ANDROID-F fluoxymesterone TABLET;ORAL 087196-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb ORA-TESTRYL fluoxymesterone TABLET;ORAL 011359-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn HALOTESTIN fluoxymesterone TABLET;ORAL 010611-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs FLUOXYMESTERONE fluoxymesterone TABLET;ORAL 088265-001 Dec 6, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb ORA-TESTRYL fluoxymesterone TABLET;ORAL 011359-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Valeant Pharm Intl FLUOXYMESTERONE fluoxymesterone TABLET;ORAL 088221-001 May 5, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs FLUOXYMESTERONE fluoxymesterone TABLET;ORAL 088309-001 Dec 6, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Medtronic
AstraZeneca
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.